Smith, Gaynor A <br/><br/>
A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).  [electronic resource] 

 -  PloS one  2015 
 - e0121072 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0121072  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Dopamine--biosynthesis<br/>Dopaminergic Neurons--metabolism<br/>Gene Expression<br/>Imidazoles--administration & dosage<br/>Inflammation--chemically induced<br/>Male<br/>Microglia--metabolism<br/>Nerve Degeneration--drug therapy<br/>Neuroprotection--drug effects<br/>Nuclear Receptor Subfamily 4, Group A, Member 2--agonists<br/>Oxidopamine--toxicity<br/>Parkinson Disease, Secondary--drug therapy<br/>Pars Compacta--drug effects<br/>Poly I-C--administration & dosage<br/>Pyridines--administration & dosage<br/>RNA, Double-Stranded<br/>Rats<br/>Toll-Like Receptor 3--biosynthesis